1.Study on clinical characteristics of basedow in combined with Hashimoto disease
Journal of Practical Medicine 2004;471(1):17-19
125 patients with Basedow disease associated with Hashimoto disease were investigated (in comparative with 88 patients subfering from single Basedow disease) at Military Hospital No 103 from January 1996 to June 2002. Results showed no difference between two groups in terms of the age of disease developing thyroid tumor of 3nd grade was occurred usually in both 2 groups, while the tumor of 4th grade occurred usually in the group of Basedow associated with Hashimoto disease. The tumor of Basedow associated with Hashimoto disease used to get high intensity, harderning in the grey and rose color while in the patient with simple Basedow disease, the tumor had low intensity, soft consistency and purple color.
Diagnosis
;
Graves Disease
;
Hashimoto Disease
2.Chromosomal aberrations and hematological indices in irradiation exposure peoples
Journal of Vietnamese Medicine 1999;232(1):26-30
We analyzed on chromosome of peripheral blood cell in comparison to hematological indices from 63 peoples between 1 and 31 years of irradiation exposure. The result showed that the aberrating rate was high in studied groups than control group significantly, especially, the rate of dysenteric choromosome. The hematological alteration is not clear yet.
Chromosome Aberrations
;
Whole-Body Irradiation
3.Some chromosome abnormality in acute leukemias classified by immunology
Journal of Vietnamese Medicine 2001;263(9):20-24
Chromosome analysis in bone marrow of leukemia patients and comparison of abnormalities between leukemia types classified by immunology using monoclonal antibodies showed that: There are chromosome abnormalities in 42 among 64 myeloid leukemia patients. Usual abnormalities are +8, t(8q; 21q+), t(15q+;17q-). In 17 lymphoblastic leukemia patients, there are 10 cases having chromosome abnormalities, the most frequent is t(9q+; 22q-). An acquired abnormalities (der 11q) added on constitutional abnormalities rob (14; 21) was detected in a myeloid leukemia patient
Leukemia
;
immunology
;
Chromosomes
4.Abnormal chromosome and progress of acute leukemia that treated by chemotherapy.
Journal of Vietnamese Medicine 2001;263(9):39-44
Analyse chromosome in bone marrow of 66 patients with myeloid leukemia and 27 patients with lymphoblastic leukemia treated in NIHBT from 1997 to 2001, in comparison with result at of some treatment, and duration of remission showed that: In myeloid leukemia, patients with translocation (8q, 21q) and translocation (15q; 17q) have favourable prognostic (they have high rate, long period of remission). In lymphoblastic leukemia, patients with philadelphia chromosome have defavourable prognostic. Although they have remission but short period of remission. It is necessary to look for another way for treatment these patients.
Leukemia
;
Chromosome Aberrations
;
Drug Therapy
;
therapeutics
5.Sexual chromosome in patients with unclear gender indentification at the national institute of hematology and blood transfusion (1996-2005)
Vinh Quang Pham ; Thuy Thi Kieu
Journal of Medical Research 2007;47(1):9-13
Background: Normally, gender of human is indentified according to enternal sexual organ. However in several cases the patient\u2019s gender is not able to identify based on enternal sexual organ. In these cases test for gender identification is need. Objectives: Identify relationship between clinical condition of the external sexual organ and sexual chromosome. Subjects and method: 119 patients with diagnosis of \u201cunclear gender identification\ufffd?made by hospitals in Ha noi. Culture of peripheral blood, analyze sexual chromosome, comparing with gender indentification proposed in neonatal period and gender indentified by physical at time of examination. Results: 87/119 cases (73,11%) have male sexual chromosome. According of gender proposed in neonatal period to sexual chromosome are 76,90% for children considered \u201cboy\ufffd?and only 33,33% for \u201cgirl\ufffd? The according percentage is higher at time of examination (mean age is 6,4 years old). There are 4 cases of female phenotype with XY sexual chromosome. Conclusion: In cases with unclear gender identification in neonatal period: 73,11% cases have male sexual chromosome (XY). Apprasal gender at neonatal period is difficulty accurate, especialy for children considered girl (the according rate is only 33,33%). \ufffd?Detect 4 cases of \u201ctesticular femiuization\ufffd?
Sex Chromosomes
;
Gender Identity
;
6.Clinical characteristics of adult acute myelogenous leukemia in National Institute of Hematology and Bloof Transfusion
Phuong Minh Vu ; Vinh Quang Pham ; Khanh Quoc Bach
Journal of Medical Research 2007;49(3):24-30
Background: In Vietnam, there are increase rate of patients with acute leukemia including acute myelogenous leukemia. The clinical, gender, age as well as morphological characteristics of cells have prognostic significance about response to treatment and survival time of patients. Objectives: (1) To describe the distribution of acute myelogenous leukemia types by FAB standard in 'National Institute of Hematology and Blood Transfusion. (2) To describe the clinical characteristics of patients with acute myelogenous leukemia. Subjects and methods: The study included 67 patients diagnosed acute myelogenous leukemia by FAB standard without chemotherapy in 'National Institute of Hematology and Blood Transfusion. Results and conclusions: The median age: 35.55 \xb1 13.46, sex: 53% male, 47% female. Ratio of M0, M1, M2, M3, M4, M5, M6, M7 was 1, 10, 19, 18, 30, 13, 6, 1 %, respectively. 100% of these patients presented with anemia, 57 % with hemorrage, 46 % with fever. Lymphadenopathy was presented in 61 %, hepatomegaly was presented in 27% and spleenomegaly was presented in 9%. 53% of the patients had more bleeding was M3. Lymphadenopathy, hepatospleenomegaly had most frequently seen in the patients of M4 and M5 type. \r\n", u'\r\n', u'
Leukemia
;
Myeloid
;
Acute/ immunology
;
Hematology
7.Application of Elisa technique for detection anti \ufffd?HLA antibodies after solid organ transplantation
Hoa Khanh Bach ; Ha Thi Thuy Hoang ; Vinh Quang Pham
Journal of Medical Research 2007;52(5):40-44
Background: Anti \ufffd?HLA (Human Leukocyte Antigen) antibody is result of immunization in allotransplantation. Organ transplantation is one of the great scientific achievements of the medicine. However, it is difficult to have the perfect harmony of HLA group. Inevitable consequence is the graft will be eliminated by the immune process. In Vietnam, organ transplantation was a relatively new specialty and there was not much research on evaluation immune process after transplantation. Objectives: To determine the rate of present of anti \ufffd?HLA antibody on transplant patients, and the role of post \ufffd?transplant anti \ufffd?HLA antibodies on long \ufffd?term graft function. Subjects and method: ELISA technique was used to analysis 31 blood samples of 31 patients who were transplanted organs at 103 military hospital and Cho Ray hospital from May 2000 to July 2007. This was a retrospective and described cross-sectional study on theclinical records. Results:The rate of anti \ufffd?HLA antibodies was 35.5%. The present of anti \ufffd?HLA antibodies of transplant patients had negative impact on graft function. Conclusion: The detection of anti \ufffd?HLA antibodies by ELISA in the post transplant period may be a high confident and sensitive technique for follows up graft function.
Organ Transplantation/ contraindications
;
HLA Antigens
;
Antibodies
;
Enzyme-Linked Immunosorbent Assay
;
8.The results of studying procedure to reduce erythrocytes from cord blood using to long-term storage of CD34 cells
Dung Thi My Pham ; Phan Trung Do ; Tung Quang Nguyen ; Vinh Quang Pham ; Tri Anh Nguyen
Journal of Medical Research 2007;51(4):1-4
Background: The reduction of erythrocytes from cord blood is very need for long - term storage of C034 cells for transplantation. Reduced erythrocyte will reduces preservative blood volume, preservatives and freely HST when defrosting, so stem cells are better protected. Objectives: To study selection of the best centrifugal procedure to reduce maximal erythrocytes and lose minimal C034 cells from cord blood. Subjects and methods: 20 blood samples selected from 60 cord blood units was used for this study. The study was carried out through two steps. In the first step, the centrifugal speed was fixed and the centrifugal time was changed.In the second step, the centrifugal time was fixed, the centrifugal speed was changed. From collected results the best appropriate procedure to reduce erythrocytes from cord blood have been selected. Results: The procedure of gradient centrifuge with speed of 500g in 6 minutes isolated> 50% of erythrocytes, kept > 84% of CD34 cells and then centrifuge of 1000 g in 10 minutes reduced about 40% of volume of nuclear cell - suspension. Conclusion: The procedure can use for preparation of stem cell suspension from cord blood to storage in nitrogen liquid. \r\n', u'\r\n', u'
Erythrocytes/ pathology
;
Fetal Blood/ chemistry
;
drug effects
;
immunology
9.Apply Nested-RT-PCR technique to identify bcr/abl fusion gene in the chronic myelogenous leukemia
Lu Thien Nguyen ; Vinh Quang Pham ; Hoa Khanh Bach ; Cuong Quoc Nguyen
Journal of Medical Research 2007;51(4):25-29
Background: Bcr/abl fusion gene plays an important role in diagnosing and treating chronic myelogenous leukemia. Objective: to detect fusion genes: b3a2, b2a2, b3a3, b2a3 and e1a2 in patients with chronic myelogenous leukemia by using Nested RT - PCR technique. Subjects and methods: Peripheral blood samples were analyzed by Nested RT - PCR assay from 30 adult patients. Results: 28/30 patients showed bcr/abl fusions gene; among them 20/30 patients showed b3a2 fusions gene, 5/30 patients showed b2a2 fusions gene, 2/30 patients showed co-expression of the b3a2 and b2a2. 1/30 showed e1a2; 2/30 patients showed negative fusion gene. Count of leukocytes and platelets of patients with b3a2 fusion genes were 311.3 G/l and 597.5 G/l, respectively and of patients with b2a2 fusion genes were 136.7 G/l and 333 G/l, respectively. Conclusion: Most of patients showed b3a2 fusion gene, while remaining showed b2a2 transcripts or the co-expression of the b3a2, only one case showed e1a2 fusion gene, two patients showed negative fusion gene. There was no case which showed b3a3 or b2a3 fusion gene. Nested RT assay should be used to determine bcr/abl fusion genes for patients with chronic myelogenous leukemia\r\n', u'\r\n', u'
Leukemia
;
Myelogenous
;
Chronic
;
BCR-ABL Positive/ blood
;
pathology
10.Application of FISH technique for detection of fusion gene ABL/BCR in chronic myelogenous leukemia
Vinh Quang Pham ; Hoang Cong Tran ; Cuong Quoc Nguyen ; Hoa Khanh Bach
Journal of Medical Research 2007;51(4):35-40
Background: Detection of BCR/ABL fusion gene has important significance in diagnosing and monitoring response to therapy in chronic myeloid leukemia. Objective: Application of FISH (Fluorescence In Situ Hybrydization) technique for detection of abl/bcr fusion gene in chronic myelogenous leukemia. Subjects and methods: The study included 10 patients of chronic myelogenous leukemia diagnosed by methods of morphology and cell chemistry. Peripheral blood and bone marrow samples of them were analyzed Philadelphia (Ph1) chromosome by cytogenetic technique. Among them, 5 patients were tested by FISH technique on the slide of interphase and remainders were tested by FISH technique on the slide of metaphase cell. Results: Results of analyzing chromosome of 10 patients showed that 8 patients had Ph1 chromosome. 2 patients without Ph1 chromosome were patients who had not high of leukocyte count: 28x109leukocyte/l and 36x109leukocyte/l, respectively. In the FISH on the slide of interphase, all 5 patients had Ph1 chromosome and abl/bcr fusion gene. In the FISH on the slide of metaphase cell, 3 patients had Ph1 chromosome and abl/bcr fusion gene. Conclusion: FISH technique has been applied successfully to detect ABL/BCR gene in patients with chronic myelogenous leukemia.\r\n', u'\r\n', u'
Leukemia
;
Myelogenous
;
Chronic
;
BCR-ABL Positive/ pathology